These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET. Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT). Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900 [TBL] [Abstract][Full Text] [Related]
5. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. Hagenimana N; Dallaire J; Vallée É; Belzile M J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460 [TBL] [Abstract][Full Text] [Related]
6. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation. Prichard RS; Cotter M; Evoy D; Gibbons D; Collins C; McDermott E; Skehan S Ir Med J; 2011 Jun; 104(6):177-9. PubMed ID: 22111394 [TBL] [Abstract][Full Text] [Related]
7. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values. Kao YH; Lim SS; Ong SC; Padhy AK Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969 [TBL] [Abstract][Full Text] [Related]
8. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies]. Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597 [TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [TBL] [Abstract][Full Text] [Related]
11. Thyroid Incidentalomas Detected on Chung SR; Choi YJ; Suh CH; Kim HJ; Lee JJ; Kim WG; Sung TY; Lee YM; Song DE; Lee JH; Baek JH Thyroid; 2018 Jun; 28(6):762-768. PubMed ID: 29759033 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287 [TBL] [Abstract][Full Text] [Related]
13. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy. Wong C; Lin M; Chicco A; Benson R Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505 [TBL] [Abstract][Full Text] [Related]
14. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients. Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results. Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467 [TBL] [Abstract][Full Text] [Related]
16. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034 [TBL] [Abstract][Full Text] [Related]
17. Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986 [No Abstract] [Full Text] [Related]
18. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Kim BH; Na MA; Kim IJ; Kim SJ; Kim YK Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]